| Drug Name: | Letrozole |
|---|---|
| Tablet Strength: | Commonly 2.5 mg film-coated oral tablets. |
| Available Packages: | Pack sizes vary by manufacturer (most commonly 28-tablet packs in the UK, though 10, 14, 30, 90, 98, or 100 tablets also exist). |
| Price: | Generic Femara (letrozole) often costs from about £4-£20 per pack of ~28-30 tablets on a private prescription, with some UK online pharmacies bringing costs into roughly £0.12-£0.65 per pill depending on supplier and quantity. |
| Rx | Prescription only. |
| Where to buy | Online Pharmacy |
Letrozole (commonly known by the brand name Femara) is a potent, prescription-only aromatase inhibitor primarily prescribed to treat hormone-receptor-positive breast cancer in postmenopausal women, as well as to induce ovulation in certain fertility treatments. Because it significantly alters hormone levels and carries strict clinical guidelines, obtaining Letrozole online safely and legally requires a formal evaluation and a valid prescription from a licensed healthcare provider. While modern telemedicine platforms offer a convenient way to connect with doctors remotely, attempting to buy Letrozole from unregulated websites without a prescription exposes you to severe health hazards. Unverified sources frequently distribute counterfeit or improperly dosed medications, and bypassing medical oversight leaves you unmonitored for serious side effects such as severe bone density loss (osteoporosis), joint pain, and cardiovascular risks.
An oncology or fertility clinician can prescribe letrozole after a video or phone visit if they have enough information to make a safe decision and can arrange any necessary tests. It has approved uses in breast cancer. Fertility specialists also prescribe it off-label to help some patients ovulate. The right appointment depends on why you need it.
How letrozole changes estrogen production
What aromatase does
Aromatase is an enzyme that converts certain androgens into estrogens. After menopause, that conversion in tissues such as fat supplies much of the body's estrogen. Letrozole is a third-generation, nonsteroidal aromatase inhibitor. It lowers estrogen production by blocking the enzyme. In breast cancer that depends on estrogen to grow, lowering the amount of estrogen available can help control the cancer or reduce the chance it will return after treatment. A pathology report that identifies estrogen receptors helps the oncology team decide whether this approach makes sense.
Why ovarian function changes the effect
Before menopause the ovaries can respond to a drop in estrogen by increasing their activity. This is one reason oncologists do not rely on an aromatase inhibitor alone when the ovaries still function. If the cancer plan calls for an aromatase inhibitor before menopause, it generally includes treatment to suppress ovarian function. Ask who will manage the suppression and what to do if an injection is delayed. The plan depends on maintaining suppression while the aromatase inhibitor is doing its job.
Why a fertility specialist may use the same drug
In a monitored fertility cycle, the temporary drop in estrogen can help the body release more follicle-stimulating hormone. This hormone supports the development of an ovarian follicle. A specialist can use that response to help a patient with an ovulation disorder release an egg. The goal is an ovulation in a planned cycle. That differs from keeping estrogen low over a long course of cancer treatment, so the dose instructions, timing, and follow-up from one setting cannot be used in the other.
Who may be offered letrozole
Treatment after surgery for early breast cancer
Letrozole has an approved use as adjuvant therapy for postmenopausal women with hormone receptor-positive early breast cancer. Adjuvant therapy aims to lower the chance that cancer will return after treatment of the primary tumor. The oncologist reviews the receptor test, tumor size, lymph node involvement, and any chemotherapy or radiation already given or planned. An early-stage diagnosis alone cannot tell the clinician which endocrine medicine has the best balance of benefit and harm for you.
Extended treatment after tamoxifen
Letrozole can also be prescribed as extended adjuvant therapy for postmenopausal women who completed a standard course of adjuvant tamoxifen. Bring the dates of your tamoxifen treatment and the original pathology to the visit. A clinician weighs the risk of a late recurrence against the adverse effects of more endocrine treatment. A patient whose cancer involved lymph nodes may face a different decision from someone with a lower risk of recurrence and a history of fractures. In MA.17, Goss and colleagues (2003) found a disease-free survival benefit when postmenopausal patients received letrozole after about five years of tamoxifen rather than placebo. This trial informs the decision to extend treatment after tamoxifen.
Locally advanced and metastatic breast cancer
The prescribing information includes first-line treatment for postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer. It also includes treatment of advanced breast cancer after progression on prior antiestrogen therapy. Receptor testing can help contemporary treatment decisions when results are available. The oncologist reviews current disease sites, prior drugs, and how quickly the cancer is changing. For some patients with hormone receptor-positive advanced disease, letrozole is part of a combination regimen that has its own monitoring requirements.
Treatment before menopause
If your periods stopped during chemotherapy, or if you are between regular cycles and menopause, your team may need more information before choosing letrozole. A history of surgery that removed both ovaries establishes a different situation from missed periods after chemotherapy. The clinician may review hormone tests when ovarian function remains uncertain. Selected patients receive an aromatase inhibitor with ovarian suppression. Other patients may be better served by a different endocrine medicine. Ask what the team will do if bleeding returns or an injection date slips.
Ovulation induction for infertility
Anovulation means that an egg does not release reliably. Letrozole is a recommended first-line option for ovulation induction in patients with polycystic ovary syndrome, or PCOS, who have infertility due to anovulation and no other identified infertility factors. This use is off-label. A diagnosis of PCOS by itself does not establish that ovulation induction is the next step. A fertility specialist considers how often you ovulate, your age and fertility history, and whether sperm or tubal factors could change the choice of treatment.
| Reason for treatment | What the clinician needs to know | What treatment aims to achieve |
|---|---|---|
| Early hormone receptor-positive breast cancer | Pathology, treatment history, and ovarian function | Reduce the chance of recurrence |
| Extended therapy after tamoxifen | Previous endocrine treatment, late recurrence risk, and bone health | Determine whether additional treatment is worthwhile |
| Advanced breast cancer | Receptor results, current disease sites, and response to earlier medicines | Control the disease and review the response over time |
| Ovulation induction | Cause of irregular ovulation, pregnancy status, and other fertility factors | Help an egg release in a planned cycle |
When an online visit makes sense
A video visit can be practical when your oncology team already has your pathology and treatment history. You might use it to discuss a recommendation made after surgery, review a recent scan, report joint symptoms, or ask about renewing a prescription. The clinician can send a prescription after the visit if they can make the decision safely and are authorized to treat you where you are. If a recent result is missing, they may need to see it before prescribing. Booking and paying for an appointment does not guarantee medication.
A fertility consultation can begin remotely with a cycle history and a review of previous tests. The clinician may need to arrange a pregnancy test, ultrasound, blood work, or an assessment of other fertility factors before starting a cycle. A new breast symptom, unexplained vaginal bleeding, or pain that needs examination can also make an in-person assessment necessary. Ask which part of the appointment can happen remotely and where the service expects you to complete the rest.
How to request a letrozole prescription online
1. Choose the service that fits your diagnosis
If the request follows a breast cancer diagnosis, contact the oncology team that holds your pathology or ask for an oncology referral. If you have irregular cycles and are trying to conceive, look for a fertility service that can investigate the cause and arrange monitoring. If your concern is a hormone result or a fertility problem in a man, book a diagnostic evaluation with an endocrinologist or reproductive urologist. A request for a particular drug alone gives the service little to work with.
2. Say whether you are starting treatment or continuing it
Mention whether your clinician already recommended letrozole and whether you have taken it before. A renewal call can focus on how you are doing, when your prescription runs out, and what follow-up is due. Starting treatment asks a different set of questions. An oncology clinician may need to confirm the receptor result and treatment sequence, while a fertility clinician may need to establish whether you ovulate and whether a cycle can start safely.
3. Send records that will affect the decision
For oncology, ask whether the service needs the pathology report, surgery summary, imaging results, and dates of earlier endocrine drugs. Add the date of your last ovarian suppression injection if you receive one. For fertility care, report the dates and length of your recent cycles and send any results the clinic requests. A brief summary is useful, but the original report can clarify details such as which tumor the receptor result belongs to or when a hormone level was measured.
4. Prepare a medication and health history
Include prescriptions, hormone products, supplements, and any fertility medicines you obtained elsewhere. Give the names and doses from the labels. Tell the clinician if you have osteoporosis, a previous fracture after a minor injury, high cholesterol, or significant liver disease. If you stopped a previous endocrine drug, say why and when. An effect that made you stop one treatment may change how your team approaches the next one.
5. Plan for in-person checks if the clinician needs them
Ask where the clinic can send requests for a bone density scan, blood work, imaging, or a fertility ultrasound. If a service is far from home, confirm that a local facility can perform the test and share the results. In fertility care, some checks are time-sensitive. Find out whom to contact if a period begins during a holiday or the clinic cannot offer a scan on the date it originally planned.
6. Ask why the clinician chose this treatment
If you are considering adjuvant therapy, ask what the oncologist expects it to change about your recurrence risk and how it compares with the other options. If you are discussing ovulation induction, ask which finding points to an ovulation disorder and how the clinic will tell whether the treatment helped. If the clinician recommends another test or a different treatment, ask what it could reveal about the decision.
7. Confirm the pharmacy and the instructions
Give the prescriber the name and address of the pharmacy you want to use. Once it receives the prescription, check the label against the treatment plan. That matters if you have an old prescription or a second medicine with different instructions. For fertility treatment, check that you have the clinic's instructions for your particular cycle before taking a tablet. Call if the dates, strength, or directions are unclear.
8. Leave with a plan for results and the next contact
A cancer care plan should explain who will review side effects and when you should request your next supply. A fertility plan should explain how to report the start of the cycle, which checks to attend, and when to test for pregnancy. Ask whom to contact if you miss a dose or receive an unexpected result. Make sure you know whether the same clinician will make the next treatment decision.
What the clinician checks during the consultation
Which breast cancer treatment plan you are following
The clinician checks whether treatment aims to lower recurrence risk after surgery or control cancer that is already advanced. That distinction affects the other medicines that may be used, the tests you need, and how your team measures benefit. Your previous endocrine drugs matter as well. If you stopped tamoxifen, the reason for stopping and the length of your course can help the oncologist assess the next option.
Whether ovarian function is clear
The clinician asks about periods, menopause symptoms, ovarian surgery, chemotherapy, and medicines that suppress ovarian function. A patient with a hysterectomy can still have functioning ovaries if they were left in place. The absence of periods in that situation cannot establish menopause. If the answer would change your cancer treatment, your oncology team can assess it using your history and any tests they consider appropriate.
Whether ovulation is the main fertility problem
A fertility history includes the timing of your cycles, how long you have been trying to conceive, previous pregnancies, and any pelvic surgery or infection. The clinician decides whether an ovulation disorder explains the problem and which other factors to check. Semen testing and an assessment of the fallopian tubes can affect the plan. The timing of tubal testing depends on your history and the proposed treatment. Ask which part of the evaluation the clinic wants completed before a prescription.
Approved and off-label uses
What approval covers
The approved breast cancer indications are for postmenopausal women and include early treatment after surgery, extended adjuvant therapy after standard tamoxifen, and specific advanced disease settings. A clinician can explain whether a proposed use is included in the product's approval or whether professional guidance supports it for your situation. The distinction matters when the standard label describes postmenopausal treatment but a specialist is considering an aromatase inhibitor with ovarian suppression before menopause.
What off-label fertility treatment means
A fertility specialist may recommend letrozole for anovulatory infertility associated with PCOS. Professional guidelines support this use in the right patients even though ovulation induction is not an approved indication in the breast cancer prescribing information. Ovulation induction aims to help someone who ovulates infrequently or not at all. Ovarian stimulation as part of assisted reproduction can serve a different purpose and follows a different clinic protocol. Ask which of these approaches the clinic is proposing before comparing dates or doses from another plan. In the trial by Legro and colleagues (2014), more participants with PCOS had a live birth after assignment to letrozole than after assignment to clomiphene. The study addressed anovulatory infertility in patients who met specific eligibility criteria. A fertility clinic still needs to check whether you have the same kind of ovulation problem and whether another factor could affect the chance of pregnancy.
Treatment in men requires a specific diagnosis
A reproductive urologist may consider an aromatase inhibitor for some men with infertility and low serum testosterone. The recommendation is conditional and the evidence is limited. Signs and symptoms, repeat hormone results when appropriate, semen findings, and the reason for a low level all shape the decision. There is no routine reason to suppress estrogen in healthy men. Letrozole has no approved use for bodybuilding or post-cycle therapy. Men with hormone receptor-positive breast cancer are a separate population. Tamoxifen is often the preferred adjuvant endocrine option for them, and if it is unsuitable, an oncologist may consider an aromatase inhibitor with suppression of testicular hormone production.
Pregnancy, trying to conceive, and breastfeeding
During breast cancer treatment
Letrozole can harm a developing fetus and is contraindicated during an existing pregnancy. The clinician should check pregnancy status before starting cancer treatment when pregnancy is possible. The prescribing information advises effective contraception during treatment and for at least three weeks after the last dose for patients who can become pregnant. It also advises against breastfeeding during treatment and for at least three weeks afterward. Ask your oncology team which method fits your situation. If you suspect pregnancy while taking letrozole for cancer, contact your prescriber promptly for advice.
Before ovulation in a fertility cycle
Fertility treatment uses letrozole before ovulation, with a plan to exclude an existing pregnancy before giving the medicine. The clinic tells you when to take the tablets, which checks it wants, and when you can try to conceive. The contraception instructions on a long-term oncology prescription apply to that cancer treatment setting. If you do not know when your cycle started, have not had the expected bleeding, or get a positive test, contact the fertility clinic before taking another dose or starting another course.
Tests and follow-up during treatment
Check bone health when planning long-term therapy
Lower estrogen during aromatase inhibitor therapy can speed up bone loss. Tell the clinician about previous fractures, osteoporosis, a family history of hip fracture, and medicines that affect bone. The team may arrange a baseline bone density scan and use it with your risk factors to decide whether you need repeat testing or bone-protective treatment. People who already have low bone density or receive ovarian suppression may need closer attention. Ask who will review the scan and whether you need a fall-prevention plan, weight-bearing and resistance exercise, or help assessing your calcium and vitamin D intake. When fracture risk warrants medication, the team can discuss the expected benefit and how to follow up.
Match other tests to your health and treatment goal
Your prescriber may check cholesterol as part of your cardiovascular risk review. A patient with high cholesterol, diabetes, or established cardiovascular disease may need an individualized plan. Routine estradiol tests are unnecessary for many patients with established menopause who take letrozole. The test can be useful in selected cases when the team is unsure whether the ovaries are still active or whether ovarian suppression is sufficient. Fertility testing answers different questions about pregnancy, follicle development, and ovulation.
| Test or assessment | When it may be useful | What it can change |
|---|---|---|
| Pathology and prior treatment records | Before starting or changing oncology treatment | Whether the cancer is likely to respond and which regimen fits |
| Bone density scan and fracture history | When planning or reviewing long-term aromatase inhibitor therapy | Follow-up interval and need for fracture prevention |
| Lipid panel | Based on your cardiovascular history and treatment plan | Whether the clinician addresses cholesterol alongside cancer treatment |
| Pregnancy test | Before oncology treatment if pregnancy is possible, or before a fertility cycle as directed | Whether it is safe to start |
| Cycle history, ultrasound, or ovulation testing | As indicated during a fertility assessment or treatment cycle | Timing and monitoring decisions for that cycle |
A result only helps if the right person receives it. Confirm which clinician will review your bone scan or lab work and what to do if you see an abnormal result in a patient portal. When your cancer treatment includes another drug, ask which tests relate to the combination. A schedule set for someone taking a second cancer medicine may not apply to a person taking letrozole alone.
Repeat prescriptions and new treatment cycles
If you take letrozole every day for cancer, ask who can renew it and when your oncology team wants to see you. Keep the latest treatment letter available if another clinician manages repeats. The dose on the pharmacy label, how many tablets you have left, and the date of your next review help the clinic decide what it needs to do. Tell the prescriber about any interruption or new medicine, especially if there has been a change in your ovarian suppression plan.
A fertility prescription belongs to the cycle for which it was written. The clinic may want to know whether you ovulated, what an ultrasound showed, and whether your pregnancy test was negative before it plans another cycle. A refill on the label does not settle those questions. If you have tablets left from an earlier cycle, confirm the dates and directions before using them. If you are transferring fertility care, send the results from your previous cycles along with the prescriptions.
How the prescriber chooses a dose
Daily treatment in oncology
The recommended dose in the breast cancer prescribing information is 2.5 mg by mouth once daily. That is the product's standard dose and your prescription should state what applies to you. Severe liver impairment with cirrhosis can change how quickly the body clears the medicine and may call for a different schedule. Tell the oncologist about any liver diagnosis or major change in your liver tests. If the hospital letter and pharmacy label give different directions, contact the prescribing team or pharmacist before taking the new supply.
Short courses in fertility care
A fertility specialist chooses a short course tied to a particular cycle. The fertility prescription should tell you how many tablets to take and which days the instructions cover. The clinic may review whether ovulation occurred before deciding on another course. An oncology prescription or someone else's cycle calendar cannot tell you which days apply to you. If you miss a dose, call the clinic for advice. The answer depends on where you are in the cycle and what the clinic is trying to measure.
How letrozole compares with other endocrine medicines
Letrozole and anastrozole
Both block aromatase and lower estrogen production. Anastrozole is one of the alternatives an oncology team may consider if letrozole causes persistent symptoms or if there is another reason to change the regimen. The drugs can share adverse effects, including joint symptoms and bone loss, yet two people may tolerate the same medicine differently. Before switching, ask how the new drug would fit the treatment goal and which symptoms or results the team plans to follow.
Letrozole and exemestane
Exemestane is a steroidal aromatase inhibitor. It inactivates the enzyme through a different mechanism from the nonsteroidal drugs. The order in which someone takes these medicines can depend on previous treatment and the cancer setting. A switch prompted by joint pain after surgery is a different decision from a change after cancer has progressed on a regimen for advanced disease. Share the dates of previous treatment and any scan that led to a change.
Letrozole and tamoxifen
Tamoxifen acts at the estrogen receptor. It can also be used in some breast cancer treatment plans before menopause. Letrozole works by lowering estrogen production and needs ovarian suppression in appropriate oncology regimens before menopause. The differences extend to adverse effects. Aromatase inhibitors can affect bone density. Tamoxifen has its own risks, including blood clots and effects on the uterine lining. A previous fracture or clot can affect the discussion without settling it on its own. The clinician needs the expected cancer benefit and your health history to compare options. In the BIG 1-98 trial, Thurlimann and colleagues (2005) reported better disease-free survival with initial letrozole than with initial tamoxifen in postmenopausal patients with hormone receptor-positive early breast cancer. That comparison applies to the adjuvant setting, where the goal is to prevent future breast cancer events.
How long treatment can continue
A common initial plan after surgery for early breast cancer is five years of endocrine treatment. Some patients are offered an extension after reassessment. If you already took tamoxifen or another aromatase inhibitor, give the oncologist the dates. They may count the whole course of endocrine treatment when considering an extension. The expected benefit of several more years varies with factors such as lymph node involvement and the risk of a later recurrence. Bone health, side effects, and your preferences also matter. Ask for a planned review date if your records only say to continue.
For advanced disease, the team reviews how the cancer responds and how you tolerate the treatment. A growing cancer or a side effect that makes the combination unsuitable may prompt a discussion of other options. Ovulation induction follows a shorter timetable. The fertility clinician reviews the response to each course and decides when to repeat the plan, investigate another cause, or change treatment. Ask how many cycles the clinic expects to review before reassessing the approach.
Side effects and symptoms that need assessment
Joint symptoms, hot flashes, and fatigue
Joint stiffness, muscle aches, hot flashes, and fatigue can make it harder to stay on treatment. Tell the oncology team when the symptom began, which joints or activities it affects, and how often it interrupts your day. A person with pre-existing arthritis may have trouble separating a new effect from their usual symptoms. The clinician can check for another cause and discuss activity, symptom management, or a change of endocrine treatment. Tell them if the symptoms are causing you to skip tablets.
Fracture risk and changes in cholesterol
Bone loss can occur without pain until a fracture happens. The risk deserves extra attention if you already have osteoporosis, have had a fracture after a minor injury, or receive ovarian suppression. A bone density result helps the clinician decide how closely to follow your bone health. Cholesterol can also rise during treatment, and you usually cannot tell by how you feel. Your team can interpret the result alongside your other cardiovascular risk factors and decide how to manage it.
| Symptom or change | What to do | What the clinician may check |
|---|---|---|
| Joint stiffness that interferes with daily activities | Report it to the oncology team before making a treatment change. | The timing of symptoms, other causes of pain, and your options for continuing treatment |
| New severe pain after a fall or minor injury | Seek prompt assessment. | Whether you have an injury or fracture and whether your bone plan needs updating |
| Chest pain, sudden shortness of breath, facial droop, or trouble speaking | Call emergency services immediately. | A heart attack, stroke, or another urgent cause |
| Severe pelvic pain, fainting, or heavy bleeding in a fertility cycle | Seek urgent medical assessment. | Causes of pain or bleeding, including pregnancy-related complications when appropriate |
| A positive pregnancy test during cancer treatment | Contact the prescribing team promptly. | Pregnancy status and how to manage the oncology prescription |
What to expect after the first prescription
After surgery, you usually will not feel letrozole lowering your future recurrence risk. Keep the follow-up schedule and ask how the breast team will monitor you. For advanced disease, the team may use imaging, symptoms, and other clinical findings to judge the response. If you receive a combination that includes letrozole, ask which clinician will review test results and how they want you to report changes between appointments.
In a fertility cycle, the team may use ultrasound, cycle information, or a progesterone test when appropriate to assess whether ovulation occurred. Ovulating and becoming pregnant are separate outcomes. If ovulation occurs and you are still having difficulty conceiving, the clinician may revisit other factors. If a response is unclear, ask which check could answer the question before the clinic changes your next prescription.
Medicines and supplements to discuss
Estrogen-containing products and other endocrine drugs
Review any estrogen-containing medicine, including hormone therapy, with your oncology team. Tell the clinician if you use a vaginal product or take anything for menopausal symptoms. The route and purpose of the product can change the discussion. If you are switching from tamoxifen, confirm the date you should take the last tablet and the date you should start letrozole. Avoid overlapping the two on your own. Tamoxifen can lower letrozole levels when they are taken together.
Medicines for bones, joints, and other conditions
List medicines and supplements you take for your bones, joints, or cholesterol along with the rest of your prescriptions. Ask whether the dose of calcium or vitamin D you already use fits your overall plan. If you are starting a medicine for a separate condition, tell the new prescriber about your cancer or fertility treatment. Carry the written plan if different clinics need to coordinate care. It can help them distinguish an intended combination from an accidental overlap.
Where to fill the prescription
A licensed pharmacy can dispense letrozole once it receives a valid prescription. Tell your clinic whether you plan to use a local or delivery pharmacy and check who handles renewals. If the pharmacy supplies a different manufacturer, confirm the tablet strength and directions. A different package or tablet appearance can be a normal change. Read the label and ask the pharmacist to resolve any discrepancy before taking the new supply.
If the prescription is for fertility treatment, ask how long dispensing takes before the planned start of the cycle. A delay may change the clinic's schedule. Contact the service for instructions if your tablets arrive after the date it gave you. If you are taking the medicine daily for breast cancer and your pharmacy cannot obtain it, call early enough for your team to check another option before you run out.
What a consultation and prescription can cost
Ask what the consultation fee includes and whether a later review carries a separate charge. A pharmacy quote covers the medicine. Blood tests, imaging, and monitoring can have their own charges. Ask for the price of the strength and quantity on your prescription so you can compare equivalent supplies. If you have health coverage, check for any limits on where you can fill the prescription or get a scan.
Cost questions differ by treatment plan. In oncology, you may need to budget for repeated supplies, bone monitoring, or visits related to another drug in the regimen. In fertility care, ask what the clinic charges for monitoring in a single cycle and how it will let you know if it recommends another scan or test. Tell your team if a cost puts you at risk of missing a refill or appointment. That gives them time to discuss a different licensed pharmacy or a practical monitoring arrangement.
How to check an online pharmacy
A legitimate pharmacy asks for a prescription, identifies where it dispenses the medicine, and provides a way to speak to a pharmacist. Verify the dispensing pharmacy through the official register for its location. If you first contact a site that advertises consultations, find out who will actually dispense the tablets. A retailer's website, a brand name on a photograph, or a customer testimonial cannot confirm the identity or strength of the medicine you will receive.
Avoid sellers who offer hormone medicines with no prescription or claim you can choose your own dose. A medicine advertised as a research product can have uncertain contents. If you already bought tablets from an unverified seller, keep the packaging and ask your pharmacist or prescriber what to do. Tell the team if you have already taken any. If you have serious symptoms, seek urgent medical help rather than waiting for a reply from the seller.
Frequently asked questions
Do I need a prescription for letrozole?
Letrozole is prescription-only. Your clinician needs to know why you would take it and whether your history or other medicines affect the decision. The prescription should give the pharmacy enough information to dispense the prescribed strength and quantity.
Can my oncologist send a first prescription after a video visit?
They may be able to do so if the relevant records are available and they can arrange follow-up. If the team needs to clarify the diagnosis, investigate a new symptom, or check ovarian function first, expect another step before treatment. Ask the clinic which records it already has when you book.
Can a fertility clinician prescribe it after an online visit?
The answer depends on what the clinic already knows about your ovulation, pregnancy status, and other fertility factors. An initial discussion can happen by video, while testing or monitoring may need a local appointment. Ask how the service handles results before the cycle starts.
Can I use letrozole to get pregnant if I have regular cycles?
Regular cycles on their own give little reason to start ovulation induction. A clinician needs to establish what could be affecting fertility and decide whether another evaluation or treatment makes more sense. The plan depends on the cause, your history, and what testing has already shown.
Why do I need a pregnancy check before fertility treatment?
The fertility clinic wants to exclude a pregnancy that already exists before you start a medicine that is used before ovulation. The clinic can tell you when to test if your periods are irregular or you are unsure which cycle day it is. Report a positive or uncertain result before taking any further tablets.
What if my periods stopped after chemotherapy?
Tell the oncology team when you last had a period and what treatments you received. Ovarian activity can return after chemotherapy. The team may use your history and, when appropriate, hormone tests to decide whether letrozole alone is suitable or whether another endocrine plan is needed.
Can I use it if I missed an ovarian suppression injection?
Contact the clinician who manages the injections. Give the scheduled date, your last actual injection date, and whether you have had any bleeding or other changes. The oncology team can decide how to handle the missed injection and what you should do with letrozole in the meantime.
How can I tell whether letrozole is working after surgery?
A change in how you feel cannot measure the reduction in recurrence risk. Keep the appointments and imaging your team recommends. Report new symptoms so the clinician can decide whether they need evaluation or could reflect a side effect.
Can I take it after finishing tamoxifen?
An oncologist may consider it as extended adjuvant treatment if the diagnosis and menopause status support that approach. Bring your old treatment dates and ask what additional benefit the team expects. The original recurrence risk and the likely effects of continued therapy help determine whether an extension fits.
Does a previous fracture mean I cannot take it?
A previous fracture is a reason to evaluate bone health. The team can assess the type of fracture, bone density, and other risk factors and discuss a plan to protect your bones. They can weigh that plan alongside the expected benefit of letrozole and other endocrine options.
Does everyone need estradiol testing?
Many people with established menopause do not need routine estradiol testing to take letrozole. In someone whose ovarian function is uncertain, or who takes medicine to suppress it, the result may change the treatment plan. Ask what question the clinician wants the test to answer.
What if joint pain makes it hard to keep taking it?
Tell the oncology team what the pain prevents you from doing and when it began. They can check for other causes and talk through symptom care or a possible switch. If you have already missed doses because of the pain, say how often so the team understands the effect on your treatment.
What if I miss a dose?
For a daily oncology prescription, follow the instructions for the product or ask your pharmacist. Avoid doubling up to make up for a dose. For a fertility course, call your clinic, since the advice depends on the timing of the cycle and the written plan.
Can a primary care clinician handle repeats?
They may be able to continue an established oncology prescription under an agreed treatment plan. Ask who will manage side effects, scans, and decisions about stopping or switching. A fertility clinic generally needs to make the decision about a new induction cycle.
Can men get a letrozole prescription?
A specialist may consider an aromatase inhibitor off-label for a specific diagnosis, such as infertility with low testosterone in selected patients. That decision follows an evaluation of symptoms, hormone levels, and reproductive factors. An isolated estradiol result does not establish a need for treatment.
Can I switch to a different aromatase inhibitor?
An oncologist can review a switch if side effects or changes in the cancer treatment plan warrant it. The reason for switching affects the choice, especially if the cancer progressed on prior therapy. Ask when to stop the current medicine, start the next one, and report symptoms.
Can I get a refill before I travel?
Ask your clinic and pharmacy how early they can arrange the prescription. Give them your travel dates and the amount you have left. If a fertility cycle overlaps the trip, ask how the clinic wants to handle any time-sensitive monitoring before you leave.
Should I continue it if I get a positive pregnancy test?
Contact the clinician who prescribed it promptly. Tell them whether the prescription was for cancer treatment or fertility care, the date of your last dose, and when you tested. Ask the team for instructions about your current prescription and the next assessment.
Can I use a tablet left over from an earlier fertility cycle?
Check with the clinic first. The clinician may need a pregnancy test or information about how you responded to the last course. Ask whether the earlier instructions still apply to your new cycle and whether the medicine is still in date.
Arrange the right consultation
For a breast cancer prescription, contact the team that can review your pathology, previous treatment, and ovarian function. If you already take letrozole, send the name of your pharmacy and the date your supply runs out. For ovulation induction, book with a fertility service that can investigate irregular ovulation and arrange the tests and monitoring your cycle requires.
- For oncology, bring your most recent treatment letter and any bone density results.
- For fertility care, have your recent cycle dates and any previous test results to hand.
- If you take an ovarian suppression medicine, give your clinician the date of the last dose.
- If a result is still pending, ask who will review it and when it can affect the prescription.
Before taking a tablet, check that the prescription directions match the treatment plan and that you know whom to contact with an unexpected result or a question about the timing.